American Pharmaceutical Partners to buy biggest shareholder
29th Nov 2005, 00:58 GMT
SCHAUMBURG, Ill. (AP) - American Pharmaceutical Partners Inc. said Monday it is buying its largest shareholder, privately held, Southern California-based American BioScience Inc., for stock worth about $4.1 billion, creating a biopharmaceutical company with annual revenue of more than $500 million. The new company will be named Abraxis BioScience and will have worldwide rights to cancer treatment Abraxane, which is marketed in the United States for metastatic breast cancer and is being developed for other breast, lung, ovarian, prostate, melanoma and head and neck cancers in more than 74 clinical trials, including seven Phase III studies.
American Pharmaceutical Partners to buy biggest shareholder related news:
- American Pharmaceutical to Buy Shareholder — RedOrbit News - Health
- Biotech firms to merge in $4b deal — Boston Globe -- Business News
- American Pharmaceutical Merges — Bio-Technology News from StratCenter.com
- American Pharm. stock slides after purchase — Chicago Sun-Times
- Drug Company Is Acquiring a Stockholder — NYT > Business
- American Pharmaceutical to merge with parent company — Pharmaceutical Business Review Online
- Am Pharm Partners to merge with parent — United Press International - Health Business
- American Pharmaceutical Partners 與母公司 American Bioscience 合併，創立 Abraxis Bioscience — UDN財經股市-股市快訊
- Steel Partners takes 12% stake in Aderans — Japan Today: Business Headlines
- American Pharmaceutical Partners Receives FDA Approval for Ampicillin and Sulbactam for Injection, USP — Operations-Related News from StratCenter.com